Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load

This study has been terminated.
(Novel HCV DAA approved by FDA)
National Science Council, Taiwan
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Information provided by (Responsible Party):
National Taiwan University Hospital Identifier:
First received: September 13, 2009
Last updated: December 19, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)